Table 3. PON1 activity in bipolar disorder (BD).
| Subjects | N | Genotyped for PON1? | PON1 Activity Substrate | Exclusion Criteria | Statistical Adjustment of the Data | Results | Refs. |
|---|---|---|---|---|---|---|---|
| Adults | CON: 64 Cases: 66 |
No | PO | Other psychiatric illnesses, epilepsy, mental retardation | Gender, BMI, alcoholic intake | ↓ POase | [46] |
| Adults | CON: 58 Cases: 59 |
Q192R | CMPA* PA |
Comorbid axis I DSM-IV condition, cognitive impairment, neurodegenerative and neuro-inflammatory disorders, inflammatory or (auto)immune disorder, use of immunoregulatory drugs, pregnancy | PON1 genotype, age, sex, BMI, smoking, mood stabilizer, education, income, MS | ↓ CMPAase* ↓ AREase |
[47] |
| Adults | CON: 199 Cases: 45 |
Q192R | PO PA |
Comorbid axis I DSM-IV condition, any major medical illness, inflammatory or infective reactions the month prior to the study, use of immunoregulatory drugs | Sex, age, BMI, education, smoking, PON1 genotype | Unaltered AREase | [38] |
Abbreviations: *CMPAase activity is equivalent to POase activity. BMI: body mass index; CMPA: 4-(chloromethyl)phenyl acetate; CON: control group; MS: metabolic syndrome; NI: not informed; PA: phenyl acetate; PO: paraoxon.